Abstract
Chronic recurrent multifocal osteomyelitis is an autoinflammatory disease that has a genetic component to disease susceptibility. It is a painful disease in which osteomyelitis occurs in one or more sites. Cultures are sterile and there is typically no improvement with antibiotics. It is associated with a personal or family history of inflammatory disease of the intestine, joints, or skin, most commonly psoriasis or Crohn’s disease. Adults can develop sterile osteomyelitis as part of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. CRMO can occur as part of a Mendelian syndrome; however, the vast majority of cases of CRMO and SAPHO syndrome are non-syndromic. Four genes have been identified that when mutated can cause sterile bone inflammation. Mutations in LPIN2, IL1RN, and FBLIM1 have been identified in humans with CRMO and Pstpip2 in a murine model of CRMO. The inflammatory bone disease in the chronic multifocal osteomyelitis (cmo) mouse is IL-1β dependent and neutrophil driven. Syndromic forms of human CRMO are also IL-1 driven, but the role of IL-1 in non-syndromic cases is not clear. Diet-driven changes in the microbiome may play a key role in disease development in murine cmo, as a high-fat diet is associated with dysbiosis and prevents disease manifestations. Fecal transplants from high-fat diet-fed cmo mice can modulate the cmo phenotype. Neutrophils from the mice fed a high-fat diet produced less IL-1β again supporting the role of the neutrophil in cmo disease pathogenesis. The role of the microbiota in human CRMO and SAPHO syndrome is unknown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CMO:
-
Chronic multifocal osteomyelitis
- CNO:
-
Chronic nonbacterial osteomyelitis
- DIRA:
-
Deficiency of the IL-1 receptor antagonist
- HFD:
-
High-fat diet
- LFD:
-
Low-fat diet
- LPS:
-
Lipopolysaccharide
- NBO:
-
Nonbacterial osteomyelitis
- NLRP3:
-
Nlr family pyrin domain containing 3
- NSAID:
-
Nonsteroidal anti-inflammatory drug
- PSTPIP2:
-
Proline-serine-threonine phosphatase-interacting protein 2
- SAPHO:
-
Synovitis, acne, pustulosis, hyperostosis, osteitis
- WB-MRI:
-
Whole-body magnetic resonance imaging
References
Jansson A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46(1):154–60.
Giedion A, et al. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol (Paris). 1972;15(3):329–42.
Probst FP, Bjorksten B, Gustavson KH. Radiological aspect of chronic recurrent multifocal osteomyelitis. Ann Radiol (Paris). 1978;21(2–3):115–25.
Girschick HJ, et al. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64(2):279–85.
Chamot AM, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987;54(3):187–96.
Jansson AF, Grote V, E.S. Group. Nonbacterial osteitis in children: data of a German incidence surveillance study. Acta Paediatr. 2011;100(8):1150–7.
Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine. 2001;68(3):245–51.
Schultz C, et al. Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J. 1999;18(11):1008–13.
Huber AM, et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141(2):198–203.
Wipff J, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67(4):1128–37.
Hedrich CM, et al. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11(1):47.
El-Shanti HI, Ferguson PJ. Chronic recurrent multifocal osteomyelitis: a concise review and genetic update. Clin Orthop Relat Res. 2007;462:11–9.
Morbach H, et al. Autoinflammatory bone disorders. Clin Immunol. 2013;147(3):185–96.
Toussirot E, Dupond JL, Wendling D. Spondylodiscitis in SAPHO syndrome. A series of eight cases. Ann Rheum Dis. 1997;56(1):52–8.
Sonozaki H, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis. 1981;40(6):547–53.
Maugars Y, et al. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesis involvement. J Rheumatol. 1995;22(11):2135–41.
Vittecoq O, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 2000;43(1):109–19.
Boutin RD, Resnick D. The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. AJR Am J Roentgenol. 1998;170(3):585–91.
Kahn MF. Why the “SAPHO” syndrome? J Rheumatol. 1995;22:2017–9.
Jurik AG. Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol. 2004;8(3):243–53.
Bousvaros A, et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44(12):2500–7.
Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol. 2007;19(5):492–8.
Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29(4):1159–77.
Khanna L, El-Khoury GY. SAPHO syndrome—a pictorial assay. Iowa Orthop J. 2012;32:189–95.
Guerin-Pfyffer S, et al. Evaluation of chronic recurrent multifocal osteitis in children by whole-body magnetic resonance imaging. Joint Bone Spine. 2012;79(6):616–20.
Mandell GA, et al. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998;39(10):1778–83.
Fritz J. The contributions of whole-body magnetic resonance imaging for the diagnosis and management of chronic recurrent multifocal osteomyelitis. J Rheumatol. 2015;42(8):1359–60.
Kennedy MT, et al. Whole body MRI in the diagnosis of chronic recurrent multifocal osteomyelitis. Orthop Traumatol Surg Res. 2012;98(4):461–4.
Bjorksten B, Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis. J Bone Joint Surg Br. 1980;62(3):376–80.
Girschick HJ, et al. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol. 1999;30(1):59–65.
Sharma M, Ferguson PJ. Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol. 2013;25(5):658–64.
Schilling F, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatol. 2000;59(5):352–3.
Beck C, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12(2):R74.
Zhao Y, et al. Physicians’ perspectives on the diagnosis and treatment of chronic nonbacterial osteomyelitis. Int J Rheumatol. 2017;2017:7694942.
Zhao Y, Laxer RM, Ferguson PJ. Treatment advances in chronic non-bacterial osteomyelitis and other autoinflammatory bone conditions. Curr Treat Options Rheum. 2017;3(1):17–32.
Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012;14(2):130–41.
Eleftheriou D, et al. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology. 2010;49(8):1505–12.
Roderick M, et al. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford). 2014;53(11):1973–6.
Hofmann SR, et al. Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol. 2016;43(11):1956–64.
Hofmann C, et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Clin Exp Rheumatol. 2014;32(4):604–9.
Park H, et al. Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol. 2012;12(8):570–80.
Aksentijevich I, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360(23):2426–37.
Reddy S, et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med. 2009;360(23):2438–44.
Jesus AA, et al. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum. 2011;63(12):4007–17.
Minkis K, et al. Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis. Arch Dermatol. 2012;148(6):747–52.
Jesus AA, Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med. 2014;65:223–44.
Ferguson PJ, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42(7):551–7.
Majeed HA, et al. The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur J Pediatr. 2001;160(12):705–10.
Rao AP, et al. Phenotypic variability in Majeed syndrome. J Rheumatol. 2016;43(6):1258–9.
Herlin T, et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis. 2013;72(3):410–3.
Lorden G, et al. Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. J Exp Med. 2016;214(2):511–28.
Cox AJ, Darbro BW, Laxer RM, Velez G, Bing X, Finer AL, Erives A, Mahajan VB, Bassuk AG, Ferguson PJ. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017;12(3):e0169687.
Golla A, et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10(3):217–21.
Hofmann SR, et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol. 2011;141(3):317–27.
Hofmann SR, et al. Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO). Int J Rheumatol. 2012;2012:310206.
Ferguson PJ, et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone. 2006;38(1):41–7.
Grosse J, et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood. 2006;107(8):3350–8.
Liao HJ, et al. Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology (Oxford). 2015;54(7):1317–26.
Byrd L, et al. Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse. Genomics. 1991;11(4):794–8.
Chitu V, et al. Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice. Blood. 2009;114(12):2497–505.
Cassel SL, et al. Inflammasome-independent IL-1beta mediates autoinflammatory disease in Pstpip2-deficient mice. Proc Natl Acad Sci U S A. 2014;111(3):1072–7.
Lukens JR, et al. Critical role for inflammasome-independent IL-1beta production in osteomyelitis. Proc Natl Acad Sci U S A. 2014;111(3):1066–71.
Lukens JR, et al. Dietary modulation of the microbiota affects autoinflammatory disease. Nature. 2014;516(7530):246–9.
Xiao G, et al. Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling. J Biol Chem. 2012;287(25):21450–60.
Hutchins AP, Poulain S, Miranda-Saavedra D. Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. Blood. 2012;119(13):e110–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ferguson, P.J. (2018). Chronic Recurrent Multifocal Osteomyelitis (CRMO). In: Ragab, G., Atkinson, T., Stoll, M. (eds) The Microbiome in Rheumatic Diseases and Infection. Springer, Cham. https://doi.org/10.1007/978-3-319-79026-8_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-79026-8_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-79025-1
Online ISBN: 978-3-319-79026-8
eBook Packages: MedicineMedicine (R0)